Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: George Dysert who wrote (918)	11/15/1997 6:42:00 PM
From: Steve Harmon	Read Replies (2) \| Respond to of 2742

To all CIST shareholders, We will be receiving a $3 million cash payment from Immunex this week. Our assets are currently valued at $5.9 million by the market. The absolute minimum value of our assets is $31 million.

To: George Dysert who wrote (918)	11/15/1997 6:54:00 PM
From: Raptech	Respond to of 2742

George: On second thought, it doesn't just apply to pennies. I hold more than a few mid and big cap stocks that do a terrible job of IR. But, if they succeed and the price appreciates I have no complaints. Really depends upon the type of investor. I just will not buy a stock where I can't obtain information on the company fundementals, and don't comprehend investors who will. At the very least, if I make a mistake it was an informed mistake based on my best info. While that's simplistic there are too many people investing on by guess and by golly! Rap